Trading for the Masses

Today After the Close
17:31 CYT Cytec beats by $0.13, beats on revs; guides FY08 EPS in-line (52.69 +0.21)

Reports Q4 (Dec) earnings of $0.96 per share, $0.13 better than the First Call consensus of $0.83; revenues rose 13.5% year/year to $901 mln vs the $852.5 mln consensus. Co issues in-line guidance for FY08, sees EPS of $4.15-4.35 vs. $4.17 consensus. “”On the input side, we expect a continuation of high raw material costs. Our expectation is that cost of crude oil will be in the range of $85 to $95 per barrel and this will have an impact on propylene derivatives, some of which are in tight supply.”
17:30 GVA Granite Constr Announces Leanne M. Stewart to Be CFO William E. Barton To Retire

…
17:29 CYT sees FY08 $4.15-4.35 vs $4.17 First Call consensus
17:28 CYT prelim $0.96 vs $0.83 First Call consensus; revs $901 mln vs $852.50 mln First Call consensus
17:26 ESLR Evergreen Solar Conference Call Update (12.36 -0.57) -Update-

Co plans to continue capacity expansion in 2008 and will incur start up costs that will impact profitability. Co does still expect to achieve profitability when Phase 1 of its Devens factory approaches full capacity. Co says it expects to complete Phase 1 of Devens factory by mid 2008 and Phase 2 in early 2009.
17:26 CCK Crown Hldgs reports Q4 (Dec) results, beats on revs (24.00 +0.06)

Reports Q4 (Dec) earnings of $2.11 per share, includes multiple items, may not be comparable to the First Call consensus of $0.17; revenues rose 11.6% year/year to $1.87 bln vs the $1.78 bln consensus.
17:23 US Senate Panel approves $157 bln Economic Stimulus plan; Includes tax rebates, unemployment benefit extension - DJ
17:22 CCK prelim $1.07, ex items, may not be comparable to $0.17 First Call consensus; revs $1.87 bln vs $1.78 bln First Call consensus
17:20 COP ConocoPhillips picked for Abu Dhabi Sour Gas project, sources say - DJ (79.13 +0.86)
17:17 NMX NYMEX: Big Nymex shareholder supports CME’s merger plan - DJ (111.37 -4.71) -Update-

DJ reports CME Group’s (CME) $11 bln bid for the co was endorsed by one of Nymex’s biggest shareholders, despite CME’s valuing Nymex at a lower price than investors had all last year. While some analysts have questioned whether Nymex shareholders will accept the combined cash-and-stock bid, which is 12% below Nymex’s price at the end of last year, many Nymex members are keen to participate in the merger mania that has gripped exchanges in recent years. “The CME and Nymex combination would be a great deal, it would create huge savings that would drop right down to the bottom line,” said Eric Bolling, a major Nymex shareholder and one of the most active traders on the exchange. “As a shareholder, I’d like to see a higher price, but not at the expense of losing the deal.” Bolling said a merger with another exchange, such as NYSE Euronext (NYX), would also deliver the same type of savings.
17:17 CSTR Coinstar Shamrock Activist Value Fund discloses 11.95% stake in amended 13D, up from 10.81% on 1/7 (29.23 -0.82)
17:14 MUR Murphy Oil announces prelim Q1, guides Q4 EPS (75.23 +1.86)

Co announces prelim Q4 EPS of $1.28, excluding $0.21 in charges, vs $1.23 First Call consensus. Co sees Q4 EOS of $1.80, including a gain, may not be comparable to $1.44 consensus. Co says, “Crude oil prices have eased a bit in January and we have experienced very tight refining margins into the new year. We anticipate total worldwide production in Q1 2008 of 125,000 barrels of oil equivalent per day, and sales volumes during the quarter should average 142,000 barrels of oil equivalent per day… Better earnings in 2007 were primarily caused by higher oil and natural gas sales prices and higher hydrocarbon sales volumes compared to 2006.”
17:12 Solar, Wind energy tax credits in Senate stimulus plan - DJ

DJ reports Solar and wind-power companies won support for a one-year extension of key tax credits, as a Senate panel included the tax breaks in an economic stimulus package. The Senate Finance Committee agreed to an economic stimulus bill Wednesday that would extend tax credits for new wind and solar projects through the end of 2009. The ultimate fate of the measure remains uncertain as President George W. Bush is trying to pressure the Senate to agree to a more limited bill passed by the House. Under the Senate Finance Committee’s measure, wind-generation companies would receive a tax credit, currently 2 cents per kilowatt hour of electricity generated, for each new wind turbine that goes into operation through 2009. The tax credit, which also would apply to electricity from geothermal and other sources, would cost $3 bln over 10 years, according to a document summarizing the details.
17:07 CEP Constellation Energy Ptnrs files a $1 bln mixed shelf offering in an S-3 (26.00 -1.2
17:07 CELG Celgene Earnings Preview (53.96 -0.32) -Update-

CELG is expected to report 4Q07 earnings before the mkt open tomorrow with a conf call to follow tomorrow at 13:30 ET… CELG Consensus: First Call 4Q07 EPS of $0.31, revs of $390.9 mln; 1Q08 EPS of $0.34, revs of $411.6 mln; FY07 EPS of $1.05, revs of $1.38 bln; FY08 EPS of $1.54, revs of $2.03 bln… Drugs Consensus: Thalomid-$103.8 mln; Revlimid-$342.3 mln… Guidance: Co guided on 1/7 press release, FY07 $1.05; FY08 Guidance of $1.45 to $1.55 - EPS is usually within a penny of analyst ests, the co has met or beat ests 6 out of the past 7 reports. Rev growth is erratic, but it seems like it has slowed down from the recent growth rate of 60%+… Expectations: The issues surrounding CELG are regarding its acquisitions of PHRM. Analysts are bullish on the acquisition and seem to think that this is a good fit but they will be looking for color on potential synergies, additional costs and the timing of the close. Analysts will also be looking for further color on Revlimid as it has run into some rough patches recently… Areas of Focus on the Call: 1) Pharmion acquisition color 2) Revlimid… Secondary Plays: PHRM… Technical Levels of Interest: Please see the Levels of Interest. Levels (Note that the length of horizontal line correlates with strength of support or resistance level) (PVIEW)
17:06 GRA W.R. Grace reports Q4 EPS of $0.58 vs $0.07 (which included Ch. 11 expenses) YoY, revs rose 15% YoY to $803.7 mln (21.67 -0.80)
17:04 SNA Snap-On beats by $0.16, beats on revs (44.00 +0.62)

Reports Q4 (Dec) earnings of $0.98 per share, $0.16 better than the First Call consensus of $0.82. “Snap-on also expects that its 2008 effective income tax rate on
earnings before minority interests and equity earnings (loss) will approximate 33%. As a result, Snap-on expects full-year 2008 sales and operating earnings to improve over 2007 levels.”
17:02 FNF Fidelity National beats by $0.10, beats on revs (17.86 +0.75)

Reports Q4 (Dec) earnings of $0.28 per share, excluding non-recurring items, $0.10 better than the First Call consensus of $0.18; revenues fell 15.6% year/year to $1.3 bln vs the $1.22 bln consensus.
17:01 FNF prelim $0.28, ex items vs $0.18 First Call consensus; revs $1.3 bln vs $1.22 bln First Call consensus
17:00 CTIC Cell Therapeutics cuts net operating expenses 35% and expands commercial team to support Zevalin sales and applications seeking two product approvals in 2009 (1.44 -0.0

Co announced that with the return of CTI to a commercial operating co through its acquisition of Zevalin (Ibritumomab Tiuxetan), the co will focus its resources on increasing the sales of Zevalin in the United States and preparing the marketing applications for XYOTAX (paclitaxel poliglumex, CT-2103) and pixantrone (BBR 2778), while supporting the advancement of brostallicin to a phase III trial. The move will reduce the Co’s projected net cash operating expenses to a forecasted $77 mln in 2008. The primary reduction in operating expenses stems from deferring or curtailing some phase III clinical trials for pixantrone and XYOTAX until planned regulatory filings and the completion of phase III studies result in product approvals. CTI expects to file for approval of XYOTAX in Europe in March. The Co will expand its commercial infrastructure for Zevalin and possible future drug sales while achieving an overall reduction in headcount.
16:59 S&P says total losses from RMBS, CDOS for financial institutions will eventually reach more than $265 bln - Reuters

Says expects upward revision of losses from some large european banks. Expects losses in the U.S. to move to regional banks, credit unions, and FHLBS. Expects outlook changes or one-notch downgrades for selected, especially thinly capitalized banks. Says downgrades will have implications for trading revenues, general business activity, bank liquidity.
16:59 SNA prelim $0.98 vs $0.82 First Call consensus; revs $742.9 mln vs $713.17 mln First Call consensus
16:55 LLY Eli Lilly Zyprexa settlement follow up (51.36 -0.96)

AS mentioned at 16:55, NY Times reports the LLY and federal prosecutors are discussing a settlement of a civil and criminal investigation into the company’s marketing of the antipsychotic drug Zyprexa that could result in Lilly’s paying more than $1 bln to federal and state governments. If a deal is reached, the fine would be the largest ever paid by a drug company for breaking the federal laws that govern how drug makers can promote their medicines. Several people involved in the investigation confirmed the settlement discussions. They insisted on anonymity because they have not been authorized to talk about the negotiations.
16:52 LLY Eli Lilly: CNBC reports that LLY is working on a settlement with federal prosecutors on Zyprexa, which could result in LLY paying $1 bln in fines (51.35 -0.96)
16:51 SYNA Synaptics Director bought 20K shares at $22.95-23.80 (24.83 +0.93)
16:50 NVLS Novellus: sees 1Q08 gross margins of 47% and total bookings to be flat to down 15% (23.41 -0.82) -Update-
16:50 NVLS Novellus: sees 1Q08 EPS of $0.21-0.24 vs consensus of $0.34 (23.41 -0.82) -Update-
16:49 NVLS Novellus: sees 1Q08 revs of $315-325 mln vs consensus of $356.02 mln (23.41 -0.82) -Update-
16:46 MER Merrill Lynch says top execs did not get bonuses for 2007 work - Reuters (56.09 -1.3 -Update-

Says President Greg Fleming to get 1.2 mln retention stock options.
16:46 AMAG AMAG Pharma provides additional clinical information on ferumoxytol; will host conference tomorrow at 9am ET (51.05 -5.64) -Update-

Co says it is seeking marketing approval for ferumoxytol as an intravenous treatment of iron deficiency anemia in patients with CKD in December 2007. The NDA is supported by data from three open-label, multi-center, randomized Phase III efficacy and safety clinical studies and a fourth Phase III safety study. The three efficacy and safety studies demonstrated a statistically significant achievement of all primary and secondary endpoints. In total, over 1,700 patients and healthy volunteers were treated with ferumoxytol in the co’s eleven clinical studies… As for morbidity and mortality rates, in the ferumoxytol clinical development program, none of these deaths were considered to be related to study treatment. The incidence of deaths following ferumoxytol treatment was lower than following oral iron treatment, and was 1.1% among ferumoxytol subjects compared to 2.8% among oral iron subjects. For deaths that occurred within 30 days of the last study treatment, the incidence was also lower with ferumoxytol, and was 0.7% among ferumoxytol subjects compared to 1.4% among oral iron subjects… As for adverse events, in the co’s three open-label, multi-center, randomized Phase III efficacy and safety clinical studies, the overall incidences of adverse events and serious adverse events occurring after study treatment were both lower following ferumoxytol treatment (2 x 510 mg) than following oral iron treatment. The AE rate was 44.0% among ferumoxytol subjects compared to 53.9% among oral iron subjects, and the SAE rate was 9.8% among ferumoxytol subjects compared to 12.1% among oral iron subjects.
16:42 MMA Municipal Mortg completes bond refinancing (7.13 -2.06)

MMA Financial, an operating subsidiary of Municipal Mortgage & Equity, announced that it has completed the refinancing of a $25 million private placement, multi-family housing mortgage revenue bond, with a major U.S. financial institution as the credit enhancement and liquidity provider. MMA Financial expects that the transaction will reduce its current financing costs for the asset by approximately 200 basis points per year.
16:36 F Ford Motor, Tata said to be nearing deal on Land Rover, Jaguar - DJ (6.75 +0.06)

DJ reports the co and TTM are nearing an agreement for Tata to buy Jaguar and Land Rover, according to a person who has been briefed on the negotiations. The deal is likely to be announced in February, perhaps as early as next week, but could be as late as the Geneva Motor Show in early March, the person said. Ford CFO Don Leclair said last week the co doesn’t plan to keep a stake in the storied British auto makers. “Our plan right now is to sell the business in its entirety,” Leclair said in a telephone interview with British newspaper the Financial Times. Ford spokesman Bill Collins confirmed the quote as accurate. The person briefed on the talks, who requested anonymity because the negotiations are private, said Tata and Ford are negotiating an agreement for Ford to keep supplying engines and other technology to Jaguar and Land Rover.
16:34 CNQR Concur Tech reports Q1 (Dec) results, beats on revs; issues Q2, Y08 guidance (28.27 +0.63)

Reports Q1 (Dec) non-GAAP earnings of $0.17 per share, may not be comparable to the First Call consensus of $0.08; revenues rose 69.2% year/year to $49.4 mln vs the $46 mln consensus. Co issues guidance for Q2, sees non-GAAP EPS of $0.17, may not be comparable to $0.10 consensus; sees Q2 revs of $50 mln vs. $48.48 mln consensus. Co issues guidance for FY08, sees non-GAAP EPS of $0.74, may not be comparable to $0.44 consensus; sees FY08 revs of $204 mln vs. $200.48 mln consensus.
16:34 ANN AnnTaylor launches strategic restructuring program to enhance profitability; reaffirms FY07 EPS (22.83 +0.23)

Co announced a multi-year restructuring program that is designed to enhance profitability and improve overall effectiveness, following the co’s comprehensive review of its SG&A cost structure. The co also announced that, in light of the ongoing macroeconomic weakness and uncertainty in the retail sector, it is taking a conservative approach to new store growth in fiscal 2008. The restructuring program is expected to result in ongoing annualized pre-tax savings of approximately $50 mln by fiscal 2010, with the benefit to fiscal 2008 expected to total approximately $20-25 mln. The total pre-tax cost to implement the program is expected to be approximately $40-45 mln, with $29 mln, or approximately $0.29 per diluted share, to be incurred in fiscal 2007. Excluding these expenses, the co indicated that it remains comfortable with its previous outlook for diluted EPS of $1.80-$1.85 for fiscal 2007 (consensus of $1.82).
16:31 CNQR sees Q2 $0.17 vs $0.10 First Call consensus; sees revs $50 mln vs $48.48 mln First Call consensus
16:31 CPRT Copart’s lanelogic partners with Pep Boys to facilitate an alternative for consumers to sell their cars for cash (40.81 -0.22)

CPRT’s lanelogic Partners and Pep Boys announce partnership program to enable consumers to obtain a cash offer for their vehicle. The program is to be piloted in the Dallas market, with a nationwide rollout expected in March.
16:31 CNQR corrected prelim $0.17 vs $0.08 First Call consensus; revs $49.40 mln vs $46.03 mln First Call consensus
16:30 CNQR prelim $0.07 vs $0.08 First Call consensus; revs $49.4 mln vs $46.03 mln First Call consensus
16:30 MIPS MIPS Techs beats by $0.06, reports revs in-line (4.19 +0.02)

Reports Q2 (Dec) earnings of $0.07 per share, excluding non-recurring items, $0.06 better than the First Call consensus of $0.01; revenues rose 26.2% year/year to $26.5 mln vs the $26.3 mln consensus.
16:29 GIL Gildan Activewear beats by $0.01, beats on revs; guides Q2 EPS below consensus; guides FY08 EPS in-line (35.67 -0.62)

Reports Q1 (Dec) earnings of $0.23 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $0.22; revenues rose 34.8% year/year to $250.5 mln vs the $241.8 mln consensus. Co issues downside guidance for Q2, sees EPS of approx $0.42 vs. $0.45 consensus. Co issues in-line guidance for FY08, sees EPS of $1.85-1.90, compared to previous guidance of $1.85, vs. $1.90 consensus.
16:29 MIPS prelim $0.07, ex items vs $0.01 First Call consensus; revs $26.5 mln vs $26.25 mln First Call consensus
16:26 TAM TAM announces buyback of up to 4 million preferred shares, equivalent to 5.56% of the total (20.89 +0.13)
16:25 DNB Dun & Bradstreet beats by $0.03, beats on revs; guides FY08 EPS in-line, revs in-line (87.92 -1.3

Reports Q4 (Dec) earnings of $1.70 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $1.67; revenues rose 8.0% year/year to $480.7 mln vs the $471.5 mln consensus. Co issues in-line guidance for FY08, sees EPS of $5.19-5.29 vs. $5.23 consensus; sees FY08 revs growth of 8-10%, which equates to ~$1.79-1.83 bln vs. $1.79 bln consensus. In 2008, DNB will continue to address complexity reduction and create financial flexibility through several initiatives. On an annualized basis, these actions are expected to create $75-80 mln of financial flexibility, of which ~$60-65 mln will be generated in 2008 before any transition costs and restructuring charges and before any reallocation of savings generated by the initiatives.
16:24 AFL AFLAC misses by $0.02, beats on revs (60.82 -1.41)

Reports Q4 (Dec) earnings of $0.78 per share, $0.02 worse than the First Call consensus of $0.80; revenues rose 8.5% year/year to $4 bln vs the $3.94 bln consensus. AFL sees FY08 sales objective of 8-12% . AFL sees Aflac Japan 2008 sales objective of an increase of 3-7%. Co issues guidance for FY08, sees EPS of $3.70-$3.76, may not be comparable to $3.83 consensus.
16:23 CAI CACI Intl misses by $0.01, reports revs in-line; raises FY08 (Jun) EPS in-line, revs in-line (42.05 -0.92)

Reports Q2 (Dec) earnings of $0.63 per share, $0.01 worse than the First Call consensus of $0.64; revenues rose 17.0% year/year to $557.8 mln vs the $559.1 mln consensus. Co raises guidance for FY08 (Jun), sees EPS of $2.60-2.80 vs. $2.70 consensus; sees FY08 (Jun) revs of $2.3-2.4 bln vs. $2.3 bln consensus.
16:22 SMCI Super Micro Computer beats single estimate by $0.04; beats on revs; guides Q3 revs above single analyst estimate (8.30 -0.03)

Reports Q3 (Dec) earnings of $0.22 per share, excluding stock-based compensation, $0.04 better than single analyst estimate of $0.47; revenues increased 20.5% year/year to $136.9 mln vs single analyst estimate of $132.00 mln consensus. Co issues upside guidance, sees Q3 revs of $137-$142 mln vs single analyst estimate of $136 mln.
16:21 CVD Covance reports EPS in-line, beats on revs (88.10 -0.95)

Reports Q4 (Dec) earnings of $0.72 per share, in-line with the First Call consensus of $0.72; revenues rose 19.8% year/year to $411 mln vs the $401.8 mln consensus.
16:21 AFL sees FY08 sales objective of 8-12%
16:20 HSTX Harris Stratex misses by $0.03, beats on revs; lowers Y08 EPS guidance, raises Y08 rev guidance (14.33 -0.99)

Reports Q2 (Dec) earnings of $0.21 per share, excluding non-recurring items, $0.03 worse than the First Call consensus of $0.24; revenues rose 79.0% year/year to $181.1 mln vs the $173.7 mln consensus. Co issues mixed guidance for FY08, sees EPS of $0.85-0.95, excluding non-recurring items, compared to previous guidance of $1.05-1.22, vs. $1.06 consensus; sees FY08 revs of $700-720 mln, compared to previous guidance of $670-702 mln, vs. $700.10 mln consensus.
16:20 TECHX Equity markets rally sharply post FOMC, then settle mostly lower in volatile last hour of trade

The stock market waited patiently for the FOMC announcement & got what it wanted in a 0.50% Fed Funds rate reduction, now standing @ 3.0%. Equity markets did exactly the opposite of what many trader’s & participants anticipated, rallying sharply to session highs & holding those gains going into the last hour of trade. However, negative news began circulating @ approx. 3:15p.m. Est coming out of the bond insurers (ABK, MBI) & coupled with a Fitch downgrade of FGIC, sellers pressured stocks & futures indices & subsequently took them down from their highs to the lows. In the end, we had mixed results as the Nasdaq 100 & Dow Tran. index finished with gains. Unofficially, INDU settled @ 12442 -37.50, SPX @ 1356 -6.50, COMPQ -2349 -9.00, NDX @1808.5 +0.80, & RUT @ 695.50 -9.70. Today’s sector strength is noted in Transports (IYT +1.6%), Semiconductors (SMH +0.90%), Gold (GLD +0.75%), & Industrials (XLI +0.40%) while weakness was seen in Homebuilders (XHB -5.3%), Energy (OIH -2.9%), Real Estate (IYR -2.7%), & Agribusiness (MOO -2.3%).
16:20 SBUX Starbucks beats by $0.01, reports revs in-line; comps well below expectations (19.22 -0.75)

Reports Q1 (Dec) earnings of $0.28 per share, $0.01 better than the First Call consensus of $0.27; revenues rose 17.5% year/year to $2.77 bln vs the $2.77 bln consensus. SBUX reports Comparable store sales growth of one percent vs +3.6% street expectation. Co expects low double digit EPS expansion for this fiscal year. In line with its announcement on January 7, 2008, Starbucks has reduced its fiscal 2008 global net new store opening target to approximately 2,150 stores, down from an adjusted 2,500 net new stores. This includes the closure of around 100 underperforming stores in the U.S. and the opening of approximately 75 additional net new stores in International markets. Co said, “We will unveil additional details of our transformation plan, including bold innovations that will reassert our coffee leadership, redefine the in-store experience and introduce core brand-building initiatives, on March 19, 2008, at the company’s Annual Meeting of Shareholders. Given all the work underway, we view 2008 as a year of refocus and renewal for Starbucks.”
16:20 CDNS Cadence Design reports EPS in-line, misses on revs (15.16 )

Reports Q4 (Dec) earnings of $0.46 per share, in-line with the First Call consensus of $0.46; revenues rose 6.3% year/year to $458 mln vs the $470.3 mln consensus. Co issues guidance for Q1, sees EPS of $0.03-$0.05, may not be comparable to $0.30 consensus; sees Q1 revs of $280-$290, may not be comparable to $393.20 mln consensus. Co issues guidance for FY08, sees EPS of $1.11-$1.19, may not be comparable to $1.53 consensus; sees FY08 revs of $1.49-$1.54, may not be comparable to $1.74 bln consensus.
16:20 AFL sees Aflac Japan 2008 sales objective of an increase of 3-7%
16:19 AFL sees FY08 $3.70-3.76 ex yen effect may not be comparable vs $3.83 First Call consensus
16:18 ARAY Accuray misses by $0.05; lowers FY08 revs below consensus (14.98 -0.1

Reports Q2 (Oct) earnings of $0.04 per share, $0.05 worse than the First Call consensus of $0.09; revenues rose 98% year/year to $52.0 mln vs the $58.2 mln consensus. Co lowers FY08 revs to $210-230 mln vs $264.8 mln consensus, down from prior $250-270 mln.
16:18 OIIM O2Micro misses by $0.01, beats on revs (8.49 -0.19)

Reports Q4 (Dec) earnings of $0.20 per share, $0.01 worse than the First Call consensus of $0.21; revenues rose 30.0% year/year to $47.2 mln vs the $46.7 mln consensus.
16:17 NVLS Novellus beats by $0.01, reports revs in-line (23.41 -0.82)

Reports Q4 (Dec) earnings of $0.37 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $0.36; revenues fell 17.1% year/year to $363.5 mln vs the $361.4 mln consensus. Co reports Q4 bookings up 12.4% q/q $343.1 mln; co reports shipments down 6.4% q/q to $363.1 mln.
16:17 EXP Eagle Materials beats by $0.03, reports revs in-line (34.53 -0.47)

Reports Q3 (Dec) earnings of $0.50 per share, $0.03 better than the First Call consensus of $0.47; revenues fell 19.2% year/year to $173 mln vs the $173.6 mln consensus.
16:16 NEWP Newport reports EPS in-line, beats on revs; guides Q1 and FY08 EPS below consensus (11.02 -0.19)

Reports Q4 (Dec) earnings of $0.20 per share, excluding non-recurring items, in-line with the First Call consensus of $0.20; revenues fell 5.5% year/year to $118.0 mln vs the $114.5 mln consensus. For Q1, co sees EPS of $0.06-0.10 vs. $0.17 consensus; sees Q1 revs of $108-114 mln vs. $111.5 mln consensus. For FY08, co sees EPS of $0.65-0.80 vs. $0.81 consensus; sees FY08 revs of $465-480 mln vs. $468.7 mln consensus.
16:16 CAI sees FY08 $2.60-2.80 vs $2.70 First Call consensus; sees revs $2.3-2.4 bln vs $2.30 bln First Call consensus
16:15 MTSN Mattson beats by $0.09, beats on revs; guides Q1 EPS below consensus, revs below consensus (6.01 -0.3

Reports Q4 (Dec) earnings of $0.09 per share, $0.09 better than the First Call consensus of ($0.00); revenues fell 37.4% year/year to $52.3 mln vs the $49.5 mln consensus. Co issues downside guidance for Q1, sees EPS of (0.11)-(0.03) vs. $0.05 consensus; sees Q1 revs of $42-$48 vs. $57.02 mln consensus. “In response to an uncertain macro-economic environment, we continue to prudently control expenses while maintaining our investments in critical R&D programs…”
16:15 EXP prelim $0.50 vs $0.47 First Call consensus; revs $173 mln vs $173.55 mln First Call consensus
16:15 DNB prelim $1.70 vs $1.67 First Call consensus; revs $480.7 mln vs $471.50 mln First Call consensus
16:15 AFL prelim $0.78 vs $0.80 First Call consensus; revs $4 bln vs $3.94 bln First Call consensus
16:14 BLOG BladeLogic reports EPS in-line, beats on revs; guides Q2 EPS below consensus, revs in-line; guides FY08 EPS below consensus, revs in-line (17.75 -0.4

Reports Q1 (Dec) earnings of $0.03 per share, in-line with the First Call consensus of $0.03; revenues rose 67.8% year/year to $21.5 mln vs the $19.8 mln consensus. Co issues mixed guidance for Q2, sees EPS of $0.01-0.02 vs. $0.03 consensus; sees Q2 revs of $20-21 mln vs. $20.22 mln consensus. Co issues mixed guidance for FY08, sees EPS of $0.08-0.12 vs. $0.17 consensus; sees FY08 revs of $86-90 mln vs. $87.65 mln consensus.
16:14 CAI prelim $0.63 vs $0.64 First Call consensus; revs $557.8 mln vs $559.08 mln First Call consensus
16:14 VIRL Virage Logic reports Q1 (Dec) results, beats on revs; guides Q2 (7.79 )

Reports Q1 (Dec) earnings of $0.06 per share, may not be comparable to the First Call consensus of $0.01; revenues rose 22.0% year/year to $14.1 mln vs the $13.8 mln consensus. Co issues guidance for Q2, sees EPS of 0.03-0.05, may not be comparable to $0.02 consensus; sees Q2 revs growing 2-5% QoQ (which calucalated to roughly $14.38-$14. vs. $14.45 mln consensus.
16:14 RE Everest Re misses by $0.19, misses on revs (97.26 +0.00)

Reports Q4 (Dec) earnings of $1.00 per share, excluding non-recurring items, $0.19 worse than the First Call consensus of $1.19; revenues fell 5.5% year/year to $1.11 bln vs the $1.14 bln consensus.
16:13 ININ Int. Intelligence beats by $0.04, misses on revs; guides FY08 revs in-line (13.59 -0.50)

Reports Q4 (Dec) earnings of $0.16 per share, excluding stock based compensation, and tax benefits may not be comparable to consensus which includes stock based compensation, $0.04 better than the First Call consensus of $0.12; revenues rose 22.5% year/year to $29.3 mln vs the $29.8 mln consensus. Co says “While cautious about 2008 given the current economic environment, we believe our competitive advantages will continue to drive revenue growth and are targeting an increase in revenues in 2008 of between 20 and 25%, along with operating margins, excluding stock option expenses, of between 10 and 11 percent.” This calculates roughly $131.88-137.37 mln vs. $132.85 mln consensus.
16:13 OPEC Secy Genl says 2Q to see surplus oil on market, according to Al Arabiya - DJ
16:13 ADPT Adaptec beats by $0.04, misses on revs (2.93 -0.02)

Reports Q3 (Dec) earnings of $0.04 per share, excluding non-recurring items, $0.04 better than the First Call consensus of ($0.00); revenues rose 178.1% year/year to $41.2 mln vs the $42.9 mln consensus.
16:13 RNOW Rightnow Tech reports EPS in-line, beats on revs; guides Q1 and FY08 EPS below consensus (12.82 +0.2

Reports Q4 (Dec) loss of $0.07 per share, excluding non-recurring items, in-line with the First Call consensus of ($0.07); revenues rose 6.6% year/year to $30.7 mln vs the $29.6 mln consensus. For Q1, co sees EPS of $(0.13)-(0.10), excluding non-recurring items, vs. ($0.04) consensus; sees Q1 revs of $31-32 mln vs. $30.95 mln consensus. For FY08, co sees EPS of $(0.16)-(0.07), excluding non-recurring items, vs. $0.00 consensus; sees FY08 revs of $135-140 mln vs. $137.9 mln consensus.
16:12 ESLR Evergreen Solar beats by $0.05, beats on revs; guides Q1 revs above consensus (11.98 -0.57)

Reports Q4 (Dec) earnings of $0.01 per share, $0.05 better than the First Call consensus of ($0.04); revenues rose 22.0% year/year to $22.2 mln vs the $20 mln consensus. Co issues upside guidance for Q1, sees Q1 revs of $21.5-22 mln vs. $20.05 mln consensus. “As we have continuously stated, we expect that Evergreen will achieve profitability when Phase 1 of our Devens factory approaches full capacity, which is expected in early 2009.”
16:12 RE prelim $1.00 vs $1.19 First Call consensus; revs $1.11 bln vs $1.14 bln First Call consensus
16:12 BLOG sees FY08 $0.08-0.12 vs $0.17 First Call consensus; sees revs $86-90 mln vs $87.65 mln First Call consensus
16:11 ADS Alliance Data reports EPS in-line, revs in-line; guides FY08 EPS above consensus (42.70 -0.30)

Reports Q4 (Dec) earnings of $0.93 per share, in-line with the First Call consensus of $0.93; revenues rose 14.9% year/year to $602.7 mln vs the $600.8 mln consensus. Co issues upside guidance for FY08, sees EPS of $4.30 vs. $4.26 consensus. During 2008, the Company expects to continue to deliver on its three long-term objectives — double-digit organic growth, solid free cash flow generation and earnings visibility. Despite various market concerns over the macro-economic environment, the Company is confident in its ability to continue to achieve double-digit organic growth in both operating and adjusted EBITDA during 2008, consistent with its previously announced goals.
16:11 CRUS Cirrus Logic misses by $0.03, reports revs in-line; guides Q4 revs in-line (4.53 -0.15)

Reports Q3 (Dec) earnings of $0.05 per share, $0.03 worse than the First Call consensus of $0.08; revenues rose 4.0% year/year to $48.9 mln vs the $49 mln consensus. Co issues in-line guidance for Q4, sees Q4 revs of $44-47 mln vs. $46.88 mln consensus. Gross margin is expected to be between 55-58%. Additionally, the co authorized a share repurchase program of up to $150 mln.
16:11 BLOG sees Q2 $0.01-0.02 vs $0.03 First Call consensus; sees revs $20-21 mln vs $20.22 mln First Call consensus
16:11 SFG StanCorp Fin beats by $0.07, reports revs in-line (45.50 -1.11)

Reports Q4 (Dec) earnings of $1.23 per share, excluding non-recurring items, $0.07 better than the First Call consensus of $1.16; revenues rose 8.1% year/year to $705.3 mln vs the $709.6 mln consensus. Co reaffirms Y08 EPS tgt of +12-15% to be achieved, reaffirms return on average equity tgt of 14-15% to be met or exceeded, sees premium growth of 6-8%, less than the long-term tgt of 10-12%.
16:11 EXPO Exponent Inc beats by $0.08; gives outlook (28.08 -0.02)

Reports Q4 (Dec) earnings of $0.33 per share, $0.08 better than the First Call consensus of $0.25; revenues rose 37.0% year/year to $56.7 mln vs the $43.5 mln consensus. Co says, “In the coming year, we expect to post high single-digit to low double-digit growth in revenue before reimbursements as we focus on capitalizing on our strategic growth areas.”
16:10 BLOG prelim $0.03 vs $0.03 First Call consensus; revs $21.461 mln vs $19.82 mln First Call consensus
16:10 MLNX Mellanox Tech announces 4Q07 EPS of $0.26; revs increased 57% from a year ago to $24.8 mln (14.51 -0.36)
16:10 AMZN Amazon.com reports EPS in-line, beats on revs; guides Q1 revs above consensus; guides FY08 revs above consensus (74.21 +0.26)

Reports Q4 (Dec) earnings of $0.48 per share, in-line with the First Call consensus of $0.48; revenues rose 42.2% year/year to $5.67 bln vs the $5.37 bln consensus. Co issues upside guidance for Q1, sees Q1 revs of $3.95-4.15 vs. $3.92 bln consensus; Operating income is expected to be between $155 million and $200 million, or to grow between 7% and 38% compared with first quarter 2007. Co issues upside guidance for FY08, sees FY08 revs of $18.75-19.75 bln vs. $18.25 bln consensus; Operating income is expected to be between $785 million and $985 million, or to grow between 20% and 50% compared with 2007.
16:09 NEWP sees FY08 $0.65-0.80 vs $0.81 First Call consensus; sees revs $465-480 mln vs $468.7 mln First Call consensus
16:09 ESLR guides Q1 revs $21.5-22 mln vs $20.05 mln First Call consensus
16:09 HRS Harris beats by $0.06, beats on revs; guides FY08 EPS above consensus, revs above consensus (49.17 -0.20)

Reports Q2 (Dec) earnings of $0.87 per share, excluding non-recurring items, $0.06 better than the First Call consensus of $0.81; revenues rose 29.7% year/year to $1.32 bln vs the $1.25 bln consensus. Co issues upside guidance for FY08, sees EPS of $3.45-3.55, excluding non-recurring items, compared to previous guidance of $3.35-3.45, vs. $3.43 consensus; sees FY08 revs of $5.2-5.3 bln vs. $5.16 bln consensus.
16:09 EGHT prelim $0.02 vs ($0.02) two analyst est; revs $15.8 mln vs $15.99 mln two analyst est
16:08 VIRL sees Q2 $0.03-0.05 excludes items may not be comp vs $0.02 First Call consensus; sees revs $14.38-14.8 mln vs $14.45 mln First Call consensus
16:08 NEWP sees Q1 $0.06-0.10 vs $0.17 First Call consensus; sees revs $108-114 mln vs $111.5 mln First Call consensus
16:08 ESLR prelim $0.01 vs ($0.04) First Call consensus; revs $22.2 mln vs $19.96 mln First Call consensus
16:08 HSTX sees FY08 $0.85-0.95 vs $1.06 First Call consensus; sees revs $700-720 mln vs $700.10 mln First Call consensus
16:07 SMCI sees Q3 revs $137-142 mln vs $136.00 mln First Call consensus
16:07 MTSN sees Q1 $(0.11)-(0.03) vs $0.05 First Call consensus; sees revs $42-48 mln vs $57.02 mln First Call consensus
16:07 SMCI prelim $0.20 vs $0.18 First Call consensus; revs $136.9 mln vs $132.00 mln First Call consensus
16:07 HSTX prelim $0.21 vs $0.24 First Call consensus; revs $181.1 mln vs $173.67 mln First Call consensus
16:07 NEWP prelim $0.20, ex-items, vs $0.20 First Call consensus; revs $118.0 mln vs $114.53 mln First Call consensus
16:06 CDNS sees FY08 $1.11-1.19 vs $1.53 First Call consensus; sees revs $1.49-1.54 bln vs $1.74 bln First Call consensus
16:06 ADPT prelim $0.04 vs $0.00 First Call consensus; revs $41.16 mln vs $42.92 mln First Call consensus
16:06 MTSN prelim $0.09 vs $0.00 First Call consensus; revs $52.3 mln vs $49.50 mln First Call consensus
16:06 VIRL prelim $0.06 excluding stock based, may not be comparable to $0.01 First Call consensus; revs $14.1 mln vs $13.80 mln First Call consensus